• No results found

immunosuppressive therapy (IST)

Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia

Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia

... plus immunosuppressive therapy (IST) treatment in comparison to IST treatment, as well as predictive factors for clinical responses, in severe aplastic anemia (SAA) ...the IST group, ...

9

High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy

High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy

... and immunosuppressive therapy in a large, well- defined cohort of SSc ...and immunosuppressive ther- apy of SSc patients in clinical practice and a marked therapeutic difference between disease ...

10

Immunosuppressive therapy in idiopathic multifocal fibrosis  A case report

Immunosuppressive therapy in idiopathic multifocal fibrosis A case report

... in 9 (82%) patients 8. Although larger studies are miss- ing, steroid administration alone or in conjunction with surgery are currently thought to be the best way of treat- ment for retroperitoneal fibrosis 1,8]. As ...

5

Progressive cutaneous Cryptococcosis complicated with meningitis in a myasthenia gravis patient on long term immunosuppressive therapy – a case report

Progressive cutaneous Cryptococcosis complicated with meningitis in a myasthenia gravis patient on long term immunosuppressive therapy – a case report

... MG is an autoimmune disease with auto-antibodies that attack specific receptors located on the surface of muscle cells preventing acetylcholine from binding to them, and thus, preventing the muscle from responding to the ...

7

High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS

High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS

... disease-modifying therapy; EDSS 5 Expanded Disability Status Scale; EFS 5 event-free survival; FDA 5 Food and Drug Administration; HALT-MS 5 High-Dose Immunosuppression and Autologous Trans- plantation for ...

12

Stem cell transplantation of matched sibling donors compared with immunosuppressive therapy for acquired severe aplastic anaemia: a Cochrane systematic review.

Stem cell transplantation of matched sibling donors compared with immunosuppressive therapy for acquired severe aplastic anaemia: a Cochrane systematic review.

... Bacigalupo (2008) 29 reported that the outcome has improved since 1996 for HSCT but not for IST. Peinemann et al 30 identi fi ed three studies that reported a statistically signi fi cant improvement of overall ...

7

Immunosuppressive therapy related adherence, beliefs and self-management in kidney transplant outpatients

Immunosuppressive therapy related adherence, beliefs and self-management in kidney transplant outpatients

... their therapy was insufficient, and main gaps in self-management comprised inadequate sun protection, incorrect administration of IS, and unfamiliarity with the IS name, or their ...

9

Graft outcomes following immunosuppressive therapy with different combinations in kidney transplant recipients: a nationwide cohort study

Graft outcomes following immunosuppressive therapy with different combinations in kidney transplant recipients: a nationwide cohort study

... Immunosuppression is induced for reducing immunologic- related graft loss after organ transplantation. All KTRs in our cohort were given at least one type of immunosuppressant during follow-up. We compared the important ...

12

Cortical Laminar Necrosis Caused by Immunosuppressive Therapy and Chemotherapy

Cortical Laminar Necrosis Caused by Immunosuppressive Therapy and Chemotherapy

... Summary: We report three patients in whom neurologic symptoms and cortical laminar necrosis developed after immunosuppressive treatment (cyclosporin A and FK 506) and polychemotherapy (vincristine and ...

6

Immunosuppressive therapy with rituximab in common variable immunodeficiency

Immunosuppressive therapy with rituximab in common variable immunodeficiency

... replacement therapy (IgRT). Although immunoglobulin therapy is also used at higher dosage in a wide range of autoimmune and inflammatory conditions for its immunomodulatory effects [47], the main indication ...

11

Recent Topics on the Mechanisms of Immunosuppressive Therapy-Related Neurotoxicities

Recent Topics on the Mechanisms of Immunosuppressive Therapy-Related Neurotoxicities

... of apoptosis in mouse brain capillary endothelial cells by cyclosporin A and tacrolimus. Nitric oxide mediates cyclosporine-induced impairment of[r] ...

39

Successful management of visceral disseminated varicella zoster virus infection during treatment of membranous nephropathy: a case report

Successful management of visceral disseminated varicella zoster virus infection during treatment of membranous nephropathy: a case report

... undergoing immunosuppressive therapy for blood diseases, kidney transplant recipients, patients with un- controlled diabetes, and patients with collagen and/or kidney ...of immunosuppressive ther- ...

7

Disseminated Exophiala dermatitidis causing septic arthritis and osteomyelitis

Disseminated Exophiala dermatitidis causing septic arthritis and osteomyelitis

... Case presentation: A 28-year-old female originally from India presented with fevers, chills, weight loss and increasing back pain. She had a recent diffuse maculopapular rash that resulted in skin biopsy and a tentative ...

5

Treatment Strategies for Childhood Steroid-Resistant Nephrotic Syndrome

Treatment Strategies for Childhood Steroid- Resistant Nephrotic Syndrome

... prednisone therapy, also after initiation of the first and second lines of immunosuppressive therapy, but values did not show significant change after the 3rd line of ...after therapy were not ...

13

Original Article Expression patterns of podocyte-associated mRNAs in patients with proliferative or non-proliferative glomerulopathies

Original Article Expression patterns of podocyte-associated mRNAs in patients with proliferative or non-proliferative glomerulopathies

... conventional immunosuppressive therapy, such as steroids, cytotoxics, and calcineurin inhibitors, reduced the urinary mRNA levels of podocin, podocalyx- in, and alpha actinin-4 concomitantly with the ...

14

Nanomedicines in renal transplant rejection – focus on sirolimus

Nanomedicines in renal transplant rejection – focus on sirolimus

... of immunosuppressive therapy is to prevent and treat organ rejection as well as prolong graft and patient ...of immunosuppressive agents (Table 1), kidney transplantation has become one of the most ...

8

Outcome of rapamycin therapy for post-transplant-lymphoproliferative disorder after kidney transplantation: case series.

Outcome of rapamycin therapy for post-transplant-lymphoproliferative disorder after kidney transplantation: case series.

... transplant. Immunosuppressive therapy for the kidney transplant recipients included combinations of cyclosporine or tacrolimus, azathioprine, prednisone and mycophenolate ...

7

Primary Angiitis of the Central Nervous System: Neurologic Deterioration Despite Treatment

Primary Angiitis of the Central Nervous System: Neurologic Deterioration Despite Treatment

... despite immunosuppressive therapy, which supports the relevance of monitoring clinical, laboratory, and radiologic re- sponses to treatment and of long-term follow-up of patients with SV ...

7

Efficacy and safety of mycophenolate mofetil in patients with IgA nephropathy: an update meta-analysis

Efficacy and safety of mycophenolate mofetil in patients with IgA nephropathy: an update meta-analysis

... and therapy regimen, renal histo- pathology was also an important factor affecting the effi- cacy of immunosuppressive ...prednisone therapy was effective in steroid-resistant ...

10

Combination treatment with oncolytic Vaccinia virus and cyclophosphamide results in synergistic antitumor effects in human lung adenocarcinoma bearing mice

Combination treatment with oncolytic Vaccinia virus and cyclophosphamide results in synergistic antitumor effects in human lung adenocarcinoma bearing mice

... this therapy, we set out to improve the outcome of the therapy by combining oncolytic virotherapy with chemotherapy using cyclophosphamide ...3B). Therapy with CPA alone resulted in a slight delay of ...

14

Show all 10000 documents...

Related subjects